DK2787968T3 - Effektiv lipidlevering til menneskelig tårefilm under anvendelse af et saltsensitivt emulsionssystem - Google Patents

Effektiv lipidlevering til menneskelig tårefilm under anvendelse af et saltsensitivt emulsionssystem Download PDF

Info

Publication number
DK2787968T3
DK2787968T3 DK12808606.3T DK12808606T DK2787968T3 DK 2787968 T3 DK2787968 T3 DK 2787968T3 DK 12808606 T DK12808606 T DK 12808606T DK 2787968 T3 DK2787968 T3 DK 2787968T3
Authority
DK
Denmark
Prior art keywords
terror
movies
human
sensitive emulsion
emulsion system
Prior art date
Application number
DK12808606.3T
Other languages
English (en)
Inventor
Peter A Simmons
Joseph G Vehige
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47459152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2787968(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK2787968T3 publication Critical patent/DK2787968T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK12808606.3T 2011-12-07 2012-12-07 Effektiv lipidlevering til menneskelig tårefilm under anvendelse af et saltsensitivt emulsionssystem DK2787968T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161568089P 2011-12-07 2011-12-07
US201261625401P 2012-04-17 2012-04-17
PCT/US2012/068603 WO2013086438A1 (en) 2011-12-07 2012-12-07 Efficient lipid delivery to human tear film using a salt-sensitive emulsion system

Publications (1)

Publication Number Publication Date
DK2787968T3 true DK2787968T3 (da) 2020-06-02

Family

ID=47459152

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12808607.1T DK2787969T3 (da) 2011-12-07 2012-12-07 Effektiv lipidlevering til human tårefilm under anvendelse af et salt-sensitivt emulsionssystem
DK12808606.3T DK2787968T3 (da) 2011-12-07 2012-12-07 Effektiv lipidlevering til menneskelig tårefilm under anvendelse af et saltsensitivt emulsionssystem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK12808607.1T DK2787969T3 (da) 2011-12-07 2012-12-07 Effektiv lipidlevering til human tårefilm under anvendelse af et salt-sensitivt emulsionssystem

Country Status (28)

Country Link
US (2) US20130150324A1 (da)
EP (4) EP2787968B1 (da)
JP (1) JP6142419B2 (da)
KR (1) KR102017922B1 (da)
CN (2) CN104114152A (da)
AR (1) AR089123A1 (da)
AU (2) AU2012347459A1 (da)
BR (1) BR112014013820A2 (da)
CA (1) CA2858574C (da)
CL (1) CL2014001518A1 (da)
CO (1) CO6990739A2 (da)
DK (2) DK2787969T3 (da)
ES (2) ES2896336T3 (da)
HK (2) HK1201458A1 (da)
HU (2) HUE049489T2 (da)
IL (1) IL233008A (da)
IN (1) IN2014CN04809A (da)
MX (1) MX355216B (da)
MY (1) MY173378A (da)
PH (1) PH12014501296A1 (da)
PL (2) PL2787968T3 (da)
PT (2) PT2787969T (da)
RU (1) RU2014127074A (da)
SG (1) SG11201403013VA (da)
SI (2) SI2787968T1 (da)
TW (1) TWI652072B (da)
WO (2) WO2013086449A1 (da)
ZA (1) ZA201404228B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
JOP20170147B1 (ar) 2016-07-07 2021-08-17 Salvat Lab Sa تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة
CN113244291A (zh) 2016-08-19 2021-08-13 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物
JP7311160B2 (ja) 2017-08-18 2023-07-19 アクリビスタ エルエルシー ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物
JP2021522264A (ja) 2018-04-27 2021-08-30 アラーガン、インコーポレイテッドAllergan,Incorporated 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
EP0028110B1 (en) * 1979-10-26 1984-03-07 Smith and Nephew Associated Companies p.l.c. Autoclavable emulsions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
IT1224795B (it) 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
DK0436726T3 (da) 1989-08-03 1993-12-27 Eisai Co Ltd Fotostabil oftalmisk opløsning og fremgangsmåde til fremstilling deraf
US5681555A (en) 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4229494A1 (de) 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
KR970705985A (ko) 1994-09-14 1997-11-03 우에하라 아끼라 각막 장해 복구용 점안제(Eye Drops for Repairing Corneal Disturbance)
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
FI106923B (fi) 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
DE69919379T2 (de) 1998-11-13 2005-09-08 Continental Projects Ltd. Komplexe von hyaluronic saure/carnitinen und pharmazeutische und kosmetische zusammensetzungen
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6228392B1 (en) 1999-04-29 2001-05-08 Gene Tools, Llc Osmotic delivery composition, solution, and method
BR0112461A (pt) 2000-07-14 2003-07-22 Allergan Inc Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
AU781975B2 (en) 2000-09-14 2005-06-23 Hayashibara Co., Ltd Pharmaceutical composition for ophthalmic use
AU2720602A (en) 2000-11-08 2002-05-21 Bio Concept Lab Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
EP1551399A4 (en) 2002-09-30 2011-01-05 Mark A Babizhayev METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT
BR0306662A (pt) * 2002-10-18 2005-02-22 Joel S Echols Formulação lacrimal de três camadas
US20040137079A1 (en) 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
WO2004084877A1 (ja) 2003-03-26 2004-10-07 Menicon Co., Ltd. 眼科用組成物
CA2527712C (en) * 2003-06-13 2014-08-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20050009836A1 (en) 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
CA2549737A1 (en) * 2003-11-10 2005-05-26 Toray Industries, Inc. Polysaccharide-containing composition and tear film stabilizing ophthalmic solution
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101896160A (zh) * 2006-10-17 2010-11-24 阿勒根公司 环胞菌素组合物
JP2010520210A (ja) 2007-02-28 2010-06-10 アーシエックス セラピューティックス, インコーポレイテッド マイボーム腺分泌を正常化するための方法および組成物
JP4929245B2 (ja) 2008-07-31 2012-05-09 株式会社ベッセル工業 工具類のグリップ
CA2764802A1 (en) * 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye

Also Published As

Publication number Publication date
PH12014501296A1 (en) 2014-10-08
HUE057140T2 (hu) 2022-04-28
TW201325633A (zh) 2013-07-01
JP2015504860A (ja) 2015-02-16
HK1203057A1 (en) 2015-10-16
PT2787968T (pt) 2020-06-16
AU2017265181B2 (en) 2019-06-20
AU2012347459A1 (en) 2014-07-03
US20130150324A1 (en) 2013-06-13
BR112014013820A8 (pt) 2017-06-13
CO6990739A2 (es) 2014-07-10
IN2014CN04809A (da) 2015-09-18
EP2787968B1 (en) 2020-03-04
SG11201403013VA (en) 2014-07-30
CN108969482A (zh) 2018-12-11
AU2017265181A1 (en) 2017-12-14
PL2787969T3 (pl) 2021-12-20
BR112014013820A2 (pt) 2017-06-13
EP2787969B1 (en) 2021-09-29
IL233008A0 (en) 2014-07-31
RU2018119362A (ru) 2018-11-08
TWI652072B (zh) 2019-03-01
CA2858574C (en) 2017-05-30
KR20140107383A (ko) 2014-09-04
EP2787968A1 (en) 2014-10-15
MY173378A (en) 2020-01-21
ES2797650T3 (es) 2020-12-03
ES2896336T3 (es) 2022-02-24
KR102017922B1 (ko) 2019-09-03
JP6142419B2 (ja) 2017-06-07
EP3666257A1 (en) 2020-06-17
US20130197083A1 (en) 2013-08-01
HUE049489T2 (hu) 2020-09-28
PL2787968T3 (pl) 2020-08-24
WO2013086449A1 (en) 2013-06-13
RU2014127074A (ru) 2016-02-10
HK1201458A1 (en) 2015-09-04
AR089123A1 (es) 2014-07-30
US9314528B2 (en) 2016-04-19
WO2013086438A1 (en) 2013-06-13
RU2018119362A3 (da) 2021-09-07
IL233008A (en) 2017-07-31
CN104114152A (zh) 2014-10-22
MX2014006804A (es) 2014-09-22
PT2787969T (pt) 2021-11-09
EP3981387A1 (en) 2022-04-13
ZA201404228B (en) 2015-12-23
MX355216B (es) 2018-04-10
SI2787968T1 (sl) 2020-08-31
CA2858574A1 (en) 2013-06-13
EP2787969A1 (en) 2014-10-15
DK2787969T3 (da) 2021-11-01
SI2787969T1 (sl) 2021-12-31
CL2014001518A1 (es) 2014-10-24

Similar Documents

Publication Publication Date Title
DK3330804T3 (da) Tonerpatron til anvendelse i en billeddannelsesindretning
DK2696839T3 (da) Fremgangsmåder til fremstilling af olie-i-vand-emulsioner
DK2549029T3 (da) Platformsystem
DK2768559T3 (da) Lægemiddelindgivelsesanordning
BR112013018828A2 (pt) sistemas de distribuição de droga
DK2786647T3 (da) Kølesystem til en server
DK3340626T3 (da) Ensrettet design til billedopdelingssystemer
DK2575935T4 (da) Anordning til indgivelse af lægemiddel
SMT201600094B (it) Sistema di aggancio oftalmico di regolazione
BR112014000266A2 (pt) toner, desenvolvedor, aparelho de formação de imagem e método de formação de imagem
DK2665503T3 (da) Medikamenttilførselsanordning
EP2781182A4 (en) PHOTOGRAPHIC DEVICE AND PHOTOGRAPHIC SYSTEM
DK2740504T3 (da) Lægemiddelfremføringsanordning
DK2787968T3 (da) Effektiv lipidlevering til menneskelig tårefilm under anvendelse af et saltsensitivt emulsionssystem
FR2975601B1 (fr) Dispositif de protection respiratoire
DK2669665T3 (da) Strålingsbilledopfangningsanordning
FR2983318B1 (fr) Dispositif diffractant
FR2972650B1 (fr) Dispositif d'administration de fluides
DK2502622T3 (da) Farmaceutisk formulering omfattende inositol
FR2972931B1 (fr) Dispositif et systeme de diffusion de parfum
BR112013033512A2 (pt) poliamida ramificada
FI20115306A0 (fi) Valon annostelulaite
DK2773241T3 (da) Fastholdelsesindretning
DK2745928T3 (da) Fremgangsmåde til emulsionsfremstilling
FI20116012A0 (fi) Elementtiperustainen verhousjärjestelmä